MedTrace Logo

Transgender, Silicone and Blood Smear

NCT02580760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2016-01-25

No results posted yet for this study

Summary

This cross-sectional monocentric study will describe transgender men transitioning into women and who had cosmetic silicone injection.

The principal objective is to estimate the prevalence of Transgender with circulating monocytes containing silicone vacuoles in blood smears among Male to Female Transgender population with a history of cosmetic silicon injections.

The secondary objectives are to describe the transgender population, to describe the quantity of silicone in vacuoles of circulating monocytes, and the association between dermatological complications (inflammatory and not inflammatory) and several clinical and biological characteristics (HIV status, level of immunosuppression, inflammatory syndrome, quantity of silicone which was injected , silicone quantity in blood smears).

Conditions

  • Injection; Complications, Sepsis
  • Injection Site Disorder
  • Injection Site Extravasation
  • Intentional Poisoning by Silicone

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Fabrice Bouscarat, MD · Hôpitaux Universitaires Paris-Nord Val de Seine, site Bichat

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580760 on ClinicalTrials.gov